Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
With
Exelixis
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histologically or cytologically confirmed small cell lung cancer, without prior chemotherapy treatment
Men and Women at least 18 years old
Eastern Cooperative Oncology Group (ECOG) status 0-2
You may not be if
Significant cardiovascular disease
Prior treatment of small cell lung cancer is not permitted, except for palliative radiation to a limited field excluding the chest (e.g. for painful metastasis).
Symptomatic brain metastases
Women pregnant or breastfeeding
Women of childbearing potential (WOCBP) unwilling/unable to use acceptable method to avoid pregnancy
Uncontrolled medical disorder or active infection
Concurrent therapy with any other investigational product
Clareo Health | A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer
